This is a further confirmation of the tissue-specific manner of CD13 glycosylation, but more importantly an indication of a distinctive sialylation pattern on CD13 in breast cancer CDX tissue tissues compared to normal healthy liver and kidney. This evidence concerns the gene ANPEP and breast carcinoma.